Thyroxine ameliorates oxidative stress by inducing lipid compositional changes in human lens epithelial cells

Area of Science:

• Cell Biology
• Biochemistry
• Ophthalmology

Background:

• Membrane lipid saturation and sphingolipids enhance resistance to oxidative damage.
• Oxidative stress in the lens is implicated in cataract development.

Purpose of the Study:

• To investigate if thyroxine treatment increases lipid saturation and sphingolipids in human lens epithelial cells (HLE B-3).
• To determine if thyroxine treatment protects these cells against lipid oxidation and improves viability under hyperoxic conditions.

Main Methods:

• HLE B-3 cells were treated with thyroxine and exposed to normoxic or hyperoxic atmospheres.
• Phospholipid composition was analyzed using mass spectrometry and NMR spectroscopy.
• Cell viability and lipid oxidation products were quantified.

Main Results:

• Thyroxine-treated cells showed 20-fold higher viability after 6 days in hyperoxia.
• Thyroxine decreased the phosphatidylcholine-to-sphingolipid ratio and increased lipid saturation.
• Lipid oxidation products were reduced by approximately 60% in thyroxine-treated cells.

Conclusions:

• Increased membrane saturation and sphingolipid content, induced by thyroxine, confer resistance to oxidative stress.
• Therapeutic strategies targeting lens sphingolipids and lipid saturation may delay cataract onset.